Log in to save to my catalogue

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by...

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83f1d7b1f7bc4c0ab9ce04a2b68715d9

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography

About this item

Full title

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography

Publisher

England: Hindawi

Journal title

Journal of diabetes research, 2022-02, Vol.2022, p.1-12

Language

English

Formats

Publication information

Publisher

England: Hindawi

More information

Scope and Contents

Contents

Purpose. To evaluate the effectiveness of intravitreal bevacizumab treatment in patients with diabetic macular edema (DME) by assessing retinal changes using optical coherence tomography angiography (OCT-A). Methods. This prospective study was performed in patients with treatment-naïve DME. The eyes of patients were imaged using a swept-source OCT...

Alternative Titles

Full title

Response to 1-Year Fixed-Regimen Bevacizumab Therapy in Treatment-Naïve DME Patients: Assessment by OCT Angiography

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_83f1d7b1f7bc4c0ab9ce04a2b68715d9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83f1d7b1f7bc4c0ab9ce04a2b68715d9

Other Identifiers

ISSN

2314-6745

E-ISSN

2314-6753

DOI

10.1155/2022/3547461

How to access this item